Official websites use .gov A .gov website belongs to an official government organization
in  the  United  States.  Secure  .gov  websites  use  HTTPS  A  lock  (   )  or  https://  means
you've  safely  connected  to  the  .gov  website.  Share  sensitive  information  only  on
official,  secure  websites.  United  States,  2024   Back  to  Child  and  Adolescent
Immunization Schedule home page Vaccines and Other Immunizing Agents in the Child
Immunization  Schedule  To  make  vaccination  recommendations,  healthcare  providers
should: CDC has developed catch-up guidance job aids to assist healthcare providers in
interpreting Table 2 in the child and adolescent immunization schedule. Children age 4
months through 6 years
The table below provides catch-up schedules and minimum intervals between doses for
children whose vaccinations have been delayed. A vaccine series does not need to be
restarted,  regardless  of  the  time  that  has  elapsed  between  doses.  Use  the  section
appropriate for the child’s age. Always use this table in conjunction with Table 1 and
the Notes that follow.
 
Vaccine
Minimum Age for Dose 1
Minimum Interval Between Doses
Dose 1 to Dose 2
Dose 2 to Dose 3
Dose 3 to Dose 4
Dose 4 to Dose 5
Hepatitis B 
Birth
4 weeks
8 weeks and at least 16 weeks after first dose.
 Minimum age for the final dose is 24 weeks
Rotavirus 
6 weeks Maximum age for first dose is 14 weeks, 6 days.
4 weeks
4 weeks
Maximum age for final dose is 8 months, 0 days
Diphtheria, tetanus, and acellular pertussis 
6 weeks
4 weeks
4 weeks
6 months
6 months
A fifth dose is not necessary if the fourth dose was administered at age 4 years or older
and at least 6 months after dose 3
Haemophilus influenzae type b 
6 weeks
No further doses needed
if first dose was administered at age 15 months or older.
4 weeks
if first dose was administered before the 1st birthday.
8 weeks (as final dose)
if first dose was administered at age 12 through 14 months.
No further doses needed
if previous dose was administered at age 15 months or older
4 weeks
If current age is younger than 12 months and first dose was administered at younger
than age 7 months and at
least 1 previous dose was PRP-T (ActHib®, Pentacel®, Hiberix®), Vaxelis® or unknown
8 weeks and age 12 through 59 months (as final dose)
if  current  age  is  younger  than  12  months  and  first  dose  was  administered  at  age  7
through 11 months;
OR
if current age is 12 through 59 months and first dose was administered before the 1st
birthday, and second dose was administered at younger than 15 months;
OR
if both doses were PedvaxHIB® and were administered before the 1st birthday
8 weeks (as final dose) 
This dose only necessary for children age 12 through 59 months who received 3 doses
before the 1st birthday.
Pneumococcal conjugate 
6 weeks
No further doses needed
for healthy children if first dose was administered at
age 24 months or older
4 weeks
if first dose administered before the
1st birthday
8 weeks (as final dose for healthy
children) 
if first dose was administered at the
1st birthday or after
No further doses needed
for healthy children if previous dose was administered at age 24 months or older
4 weeks
if current age is younger than 12 months and previous dose given at <7 months old
8 weeks (as final dose for healthy children)
if previous dose given between 7-11 months (wait until at least 12 months old);
OR
if current age is 12 months or older and at least 1 dose was administered before age 12
months
8 weeks (as final dose)
This dose is only necessary for children age 12 through 59 months regardless of risk, or
age 60 through 71 months with any risk, who received 3 doses before age 12 months.
Inactivated poliovirus 
6 weeks
4 weeks
4 weeks
if current age is <4 years
6 months
(as final dose) if current age is 4 years or older
6 months
(minimum age 4 years for final dose)
Measles, mumps, rubella 
12 months
4 weeks
Varicella 
12 months
3 months
Hepatitis A 
12 months
6 months
Meningococcal ACWY 
2 months MenACWY-CRM
2 years MenACWY-TT
8 weeks
See notes
See notes
Top of Page
Children and adolescents age 7 through 18 years
 
Vaccine
Minimum Age for Dose 1
Minimum Interval Between Doses
Dose 1 to Dose 2
Dose 2 to Dose 3
Dose 3 to Dose 4
Meningococcal ACWY 
Not Applicable (N/A)
8 weeks
Tetanus, diphtheria; tetanus, diphtheria, and acellular pertussis 
7 years
4 weeks
4 weeks
if first dose of DTaP/DT was administered before the 1st birthday
6 months (as final dose)
if first dose of DTaP/DT or Tdap/Td was administered at or after the 1st birthday
6 months
if first dose of DTaP/DT was administered before the 1st birthday
Human papillomavirus 
9 years
Routine dosing intervals are recommended.
Hepatitis A 
N/A
6 months
Hepatitis B 
N/A
4 weeks
8 weeks and at least 16 weeks after first dose.
Inactivated poliovirus 
N/A
4 weeks
6 months
A fourth dose is not necessary if the third dose was administered at age 4 years or older
and at least 6 months after the previous dose.
A fourth dose of IPV is indicated if all previous doses were administered at <4 years OR
if the third dose was administered <6 months after the second dose.
Measles, mumps, rubella 
N/A
4 weeks
Varicella 
N/A
3 months if younger than age 13 years.
4 weeks if age 13 years or older
Dengue 
9 years
6 months
6 months
To make vaccination recommendations, healthcare providers should:
Determine recommended vaccine by age (Table 1 – By Age)
Determine recommended interval for catch-up vaccination (Table 2 – Catch-up)
Assess  need  for  additional  recommended  vaccines  by  medical  condition  or  other
indication (Table 3 – By Medical Indication)
Review vaccine types, frequencies, intervals, and considerations for special situations
(Notes)
Review contraindications and precautions for vaccine types (Appendix)
Review new or updated ACIP guidance (Addendum)
Recommended  by  the  Advisory  Committee  on  Immunization  Practices  (ACIP)  and
approved by the Centers for Disease Control and Prevention (CDC), American Academy
of Pediatrics (AAP), American Academy of Family Physicians (AAFP), American College
of  Obstetricians  and  Gynecologists  (ACOG),  American  College  of  Nurse-Midwives
(ACNM), American Academy of Physician Associates (AAPA), and National Association of
Pediatric Nurse Practitioners (NAPNAP).
The comprehensive summary of the ACIP recommended changes made to the child and
adolescent immunization schedule can be found in the January 11, 2024 MMWR.
Report
Suspected cases of reportable vaccine-preventable diseases or outbreaks to your state
or local health department
Clinically  significant  adverse  events  to  the  Vaccine  Adverse  Event  Reporting  System
(VAERS) at www.vaers.hhs.gov or (800-822-7967)
Questions or comments
Contact www.cdc.gov/cdc-info or 800-CDC-INFO (800-232-4636), in English or Spanish,
8 a.m.–8 p.m. ET, Monday through Friday, excluding holidays.
Helpful information
Complete Advisory Committee on Immunization Practices (ACIP) recommendations
ACIP Shared Clinical Decision-Making Recommendations
General  Best  Practice  Guidelines  for  Immunization  (including  contraindications  and
precautions)
Vaccine information statements
Manual  for  the  Surveillance  of  Vaccine-Preventable  Diseases  (including  case
identification and outbreak response)
 The table below provides catch-up schedules and minimum intervals between doses for
children whose vaccinations have been delayed. A vaccine series does not need to be
restarted,  regardless  of  the  time  that  has  elapsed  between  doses.  Use  the  section
appropriate for the child’s age. Always use this table in conjunction with Table 1 and
the Notes that follow. This dose only necessary for children age 12 through 59 months
who  received  3  doses  before  the  1st  birthday.  2  years  MenACWY-TT  Top  of  Page  To
make  vaccination  recommendations,  healthcare  providers  should:  Recommended  by
the Advisory Committee on Immunization Practices (ACIP) and approved by the Centers
for  Disease  Control  and  Prevention  (CDC),  American  Academy  of  Pediatrics  (AAP),
American Academy of Family Physicians (AAFP), American College of Obstetricians and
Gynecologists  (ACOG),  American  College  of  Nurse-Midwives  (ACNM),  American
Academy  of  Physician  Associates  (AAPA),  and  National  Association  of  Pediatric  Nurse
Practitioners  (NAPNAP).  The  comprehensive  summary  of  the  ACIP  recommended
changes made to the child and adolescent immunization schedule can be found in the
January 11, 2024 MMWR. Report Questions or comments
Contact www.cdc.gov/cdc-info or 800-CDC-INFO (800-232-4636), in English or Spanish,
8 a.m.–8 p.m. ET, Monday through Friday, excluding holidays. Helpful information
Source URL: https://www.cdc.gov/vaccines/schedules/hcp/imz/catchup.html
